The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $3.58 in the prior trading day, Aquestive Therapeutics Inc (NASDAQ: AQST) closed at $3.30, down -7.82%. In other words, the price has decreased by -$7.82 from its previous closing price. On the day, 2.55 million shares were traded. AQST stock price reached its highest trading level at $3.59 during the session, while it also had its lowest trading level at $3.26.
Ratios:
Our goal is to gain a better understanding of AQST by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.91 and its Current Ratio is at 6.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on December 17, 2024, initiated with a Overweight rating and assigned the stock a target price of $17.
On May 10, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $8.
On April 11, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $10.Piper Sandler initiated its Overweight rating on April 11, 2024, with a $10 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 26 ’24 when Jung Cassie sold 44 shares for $4.87 per share. The transaction valued at 214 led to the insider holds 0 shares of the business.
Schobel Alexander Mark sold 50,000 shares of AQST for $300,000 on Mar 15 ’24. The Chief Innovation/Tech Officer now owns 984,476 shares after completing the transaction at $6.00 per share. On Mar 08 ’24, another insider, Schobel Alexander Mark, who serves as the Chief Innovation/Tech Officer of the company, sold 25,000 shares for $5.19 each. As a result, the insider received 129,685 and left with 1,040,371 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AQST now has a Market Capitalization of 300888064 and an Enterprise Value of 259864032. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.98. Its current Enterprise Value per Revenue stands at 4.412 whereas that against EBITDA is -12.969.
Stock Price History:
The Beta on a monthly basis for AQST is 2.68, which has changed by 0.3161764 over the last 52 weeks, in comparison to a change of 0.24933672 over the same period for the S&P500. Over the past 52 weeks, AQST has reached a high of $6.23, while it has fallen to a 52-week low of $2.07. The 50-Day Moving Average of the stock is -25.79%, while the 200-Day Moving Average is calculated to be -16.51%.
Shares Statistics:
The stock has traded on average 1.47M shares per day over the past 3-months and 1152180 shares per day over the last 10 days, according to various share statistics. A total of 91.18M shares are outstanding, with a floating share count of 77.61M. Insiders hold about 14.88% of the company’s shares, while institutions hold 45.95% stake in the company. Shares short for AQST as of 1734048000 were 9653937 with a Short Ratio of 6.58, compared to 1731628800 on 9965234. Therefore, it implies a Short% of Shares Outstanding of 9653937 and a Short% of Float of 12.68.
